Researchers have identified a specific genetic pattern that may contribute to blood clots in the brain among younger people.

If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs ...

Though they are common and pose little risk, varicose veins can cause distress and some seek to have them removed. Here’s ...

Positive CHMP opinion is supported by data from the Phase 3 UP-AA clinical program in which upadacitinib achieved the primary endpoint of Severity of Alopecia Tool (SALT) score = 20 and key ...

ADC Therapeutics SA , a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced the completion of enrollment in the LOTIS-7 Phase 1b open-label ...

As you all know, Alnylam is pioneering an entirely new class of medicines to treat human disease. This generational technology leverages the mechanism of RNA interference, a natural process of gene ...

Blood clots are a serious health problem that affect millions of people around the world every year. While blood clotting is a normal process that helps stop bleeding after an injury, clots that form ...

Researchers have validated a genetic scoring tool that may help physicians diagnose idiopathic pulmonary fibrosis and ...

Mass General Brigham has started offering a blood test that estimates a person’s inherited risk for eight different ...

Researchers at The University of Texas MD Anderson Cancer Center have identified why some patients with a rare type of ...